Sarah Stiles
Family · Morgantown, WVNPI 1285364935
Payments from drug & device makers
Across 257 payments — averaging $17.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$825
- Axsome Therapeutics, Inc.$801
- Otsuka America Pharmaceutical, Inc.$597
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$570
- Alkermes, Inc.$467
- Teva Pharmaceuticals USA, Inc.$258
- plus $999 from 12 others
What the payments were for
- Food & beverage$4,517100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 61 | $825 |
| Axsome Therapeutics, Inc. | 31 | $801 |
| Otsuka America Pharmaceutical, Inc. | 34 | $597 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 37 | $570 |
| Alkermes, Inc. | 19 | $467 |
| Teva Pharmaceuticals USA, Inc. | 15 | $258 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $157 |
| Indivior Inc. | 8 | $151 |
| Lundbeck LLC | 9 | $142 |
| Neurocrine Biosciences, Inc. | 9 | $139 |
| Corium, LLC | 5 | $93 |
| Sunovion Pharmaceuticals Inc. | 6 | $86 |
| Johnson & Johnson | 4 | $70 |
| Ironshore Pharmaceuticals Inc. | 3 | $53 |
| Neos Therapeutics, LP | 3 | $49 |
| Almatica Pharma LLC | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Tris Pharma Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,517 in reported general payments places this provider in the 90th percentile of 1,507 family providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SpravatoEsketamine Hcl | 91 | $108,746 |
| Lurasidone Hcl | 32 | $2,679 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 25 | $616 |
| Duloxetine Hcl | 16 | $310 |
| Methylphenidate Hcl | 25 | $232 |
| Olanzapine | 21 | $220 |
| Clonazepam | 27 | $164 |
| Lamotrigine | 40 | $160 |
| Alprazolam | 26 | $116 |
| Diazepam | 17 | $78 |
| Escitalopram Oxalate | 12 | $63 |
| Amitriptyline Hcl | 12 | $50 |
| Clonidine Hcl | 12 | $27 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonSpravato | $70 | $108,74691 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,507 family providers in West Virginia.
Other family in Morgantown
- Justin HayesMorgantown$12K
- John HuberMorgantown$12K
- Peggy FergusonMorgantown$9K
- Samantha KingMorgantown$7K
- Ashley ComerCharleston$213K
- Dana CruseParkersburg$109K
- Sarah KnightCharleston$99K
- Star RoeBarboursville$55K
- Angela SettleCharleston$51K
- Amber DuncanCross Lanes$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.